WORLD CONFERENCE FOR REGENERATIVE MEDICINE: DEADLINE EXTENSION UNTIL 24 JUNE 2013

For Leipzig’s conference, one of the most renowned stem cell researchers from the partner country Canada, Mick Bhatia could be acquired. His talk entitled “Differentiation and Conversion of Human Cell Fate: Plasticity and Pluripotency” will be part of the opening event on Wednesday evening. The highly reputable German stem cell researcher Hans Schöler is also going to attend the evening program. His lecture will bring deeper information on iPS (induced pluripotent stem) cells and noval approaches for their application on treatment of neurodegenerative diseases. Further scientific highlights are the talks of Irvin Weissman and Robert Lanza on the topics “Normal and tumor stem cells” and “Embryonic stem cells and iPS on the way to the clinic”.

In addition to the scientific program, the event will serve as a platform for informal exchanges and networking. A versatile evening program with an opening event, a get-together, a poster party and a social evening event in the Gondwanaland, Europe’s largest tropical experience world in Leipzig Zoo, offers participants the possibility to network with their colleagues in science and business.

Abstracts can be submitted until 24 June. Registration, abstract submission and ticket booking for the social event will be made online on the conference website www.wcrm-leipig.com.

The World Conference on Regenerative Medicine is taking place for the sixth consecutive time. Every two years, the Conference is organized by the Fraunhofer Institute for Cell Therapy and Immunology IZI and the Translational Centre for Regenerative Medicine (TRM) of the Universität Leipzig.

The Fraunhofer Institute for Cell Therapy and Immunology IZI

The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops specific problem solutions at the interfaces of medicine, life sciences and engineering. The Institute practices contract research for biotechnological, pharmaceutical and medical-technological companies, hospitals, diagnostic laboratories and research facilities. Within the Business Units of Agents, Cell Therapy, Diagnostic and Bio-banking, the Institute develops, optimizes and validates methods, materials and products. The Institute’s core competencies are located in the field of regenerative medicine, in particular in the indication areas of oncology, ischemia as well as autoimmune, inflammatory and infectious diseases. The Institute is clinically oriented, conducts quality checks and GMP-compliantly manufactures investigational medicinal products Moreover, the Institute provides support in obtaining manufacturing authorizations and approvals.

The Translational Centre for Regenerative Medicine (TRM) Leipzig

The Translational Centre for Regenerative Medicine (TRM) of the Universität Leipzig develops novel diagnostic and therapeutic methods of regenerative medicine and enables the rapid transfer of results into clinical applications. Cell biological methods, immunological working procedures, imaging studies and systems biology approaches collectively cover all aspects of translational research. In addition, the TRM Leipzig has established an academic education program to strengthen the competence of application-oriented experts in the field of regenerative medicine.
The TRM Leipzig supports scientists and companies in developing advanced therapy medicinal products (ATMP). The portfolio comprises a wide range of non-clinical services to demonstrate quality, safety and efficacy of medicinal products, practical seminars on good laboratory practice (GLP) and support in matters of regulation.
Since its foundation in 2006, the TRM Leipzig has been funded by the Federal Ministry for Education and Research (BMBF) and the Free State of Saxony.

Scroll to Top